<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In both <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>, the secondary prevention of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> basically relies on the histological detection of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel diseases</z:e>, <z:mpath ids='MPATH_589'>dysplasia</z:mpath> identifies the subgroup of patients eligible for stricter surveillance (or prophylactic colectomy) </plain></SENT>
<SENT sid="2" pm="."><plain>In clinical practice, a number of issues may influence the benefits of clinico-pathological surveillance for <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> patients with <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, including: sampling errors, inconsistent biopsy assessments, patients' compliance with follow-up requirements, and how heath care is organized </plain></SENT>
<SENT sid="3" pm="."><plain>Even in such a multifaceted context, it has been demonstrated that <z:mpath ids='MPATH_589'>dysplasia</z:mpath> surveillance is effective in reducing <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>-related mortality and morbidity </plain></SENT>
<SENT sid="4" pm="."><plain>This paper focuses on current issues concerning the histological assessment of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e>-associated dysplastic lesions </plain></SENT>
</text></document>